Trial Profile
A 48-Week, Multicentre, Multinational, Randomized, Double-Blind, 2-Arm Parallel Group, Comparing the Efficacy of Foster for Maintenance and Reliever Versus Fixed-Dose Foster for Maintenance Plus Salbutamol as Reliever in Asthmatics > or = 18 Years of Age
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Oct 2021
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Salbutamol
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors Chiesi Farmaceutici
- 21 Apr 2012 Planned number of patients changed from 2404 to 2482 as reported by European Clinical Trials Database.
- 21 Apr 2012 Additional trial locations added as reported by European Clinical Trials Database.
- 16 Feb 2012 Actual patient number is 2079 according to ClinicalTrials.gov.